117 related articles for article (PubMed ID: 25203777)
1. Discovery of potential and selective COX-1 inhibitory leads using pharmacophore modelling, in silico screening and in vitro evaluation.
Balaji B; Hariharan S; Shah DB; Ramanathan M
Eur J Med Chem; 2014 Oct; 86():469-80. PubMed ID: 25203777
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
[TBL] [Abstract][Full Text] [Related]
3. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
5. 'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.
Handler N; Brunhofer G; Studenik C; Leisser K; Jaeger W; Parth S; Erker T
Bioorg Med Chem; 2007 Sep; 15(18):6109-18. PubMed ID: 17604631
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
[TBL] [Abstract][Full Text] [Related]
7. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory mode of 2-acetoxyphenyl alkyl sulfides against COX-1 and COX-2: QSAR analyses.
Jain HK; Mourya VK; Agrawal RK
Bioorg Med Chem Lett; 2006 Oct; 16(20):5280-4. PubMed ID: 16908140
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.
Seebacher W; Faist J; Presser A; Weis R; Saf R; Kaserer T; Temml V; Schuster D; Ortmann S; Otto N; Bauer R
Eur J Med Chem; 2015 Aug; 101():552-9. PubMed ID: 26197159
[TBL] [Abstract][Full Text] [Related]
13. Novel pyrazolopyrimidine derivatives targeting COXs and iNOS enzymes; design, synthesis and biological evaluation as potential anti-inflammatory agents.
Abdelazeem AH; Abdelatef SA; El-Saadi MT; Omar HA; Khan SI; McCurdy CR; El-Moghazy SM
Eur J Pharm Sci; 2014 Oct; 62():197-211. PubMed ID: 24907682
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of 2-substituted-1-naphthol derivatives on cyclooxygenase I and II.
Kongkathip B; Sangma C; Kirtikara K; Luangkamin S; Hasitapan K; Jongkon N; Hannongbua S; Kongkathip N
Bioorg Med Chem; 2005 Mar; 13(6):2167-75. PubMed ID: 15727869
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR/3D-QSAR studies on the COX-2 inhibitory activity of 1,5-diarylpyrazoles to validate the modified pharmacophore.
Singh SK; Saibaba V; Rao KS; Reddy PG; Daga PR; Rajjak SA; Misra P; Rao YK
Eur J Med Chem; 2005 Oct; 40(10):977-90. PubMed ID: 15961192
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modeling for COX-1 and -2 inhibitors with LigandScout in comparison to Discovery Studio.
Temml V; Kaserer T; Kutil Z; Landa P; Vanek T; Schuster D
Future Med Chem; 2014; 6(17):1869-81. PubMed ID: 25495981
[TBL] [Abstract][Full Text] [Related]
18. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
Rollinger JM; Haupt S; Stuppner H; Langer T
J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
[TBL] [Abstract][Full Text] [Related]
19. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Abdel-Aziz AA; ElTahir KE; Asiri YA
Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]